Fact checks · Devices and procedures
“Can opening blocked neck veins liberate me from MS?”
The bottom line
Sham-controlled trials found that venous angioplasty does not meaningfully treat MS, making the CCSVI "liberation" procedure a historical example of an appealing claim that failed controlled testing.
Why people are talking about it
Paolo Zamboni's hypothesis linked MS to impaired drainage through veins in the neck and chest. Dramatic patient accounts, media coverage and online campaigning helped turn the proposed "liberation procedure" into a medical-tourism treatment before reliable trial results were available.
What the research says
The Brave Dreams randomized, double-blind, sham-controlled trial included 115 participants with relapsing-remitting MS in its principal analysis. Balloon angioplasty did not improve the primary functional outcome or significantly reduce the prespecified overall new combined MRI lesion outcome across 12 months compared with sham treatment. Some exploratory MRI analyses attracted attention, but they did not establish a clinical benefit. Jagannath and colleagues' 2019 Cochrane review combined three sham-controlled studies involving 238 participants. It found no benefit for disability, physical or cognitive function, relapses or quality of life and concluded that venous angioplasty could not be recommended for MS.
What we don't know yet
The trials were too small to precisely quantify uncommon serious complications. That limitation does not reverse the negative efficacy findings or justify offering the procedure as MS treatment. A separate, genuine vascular disorder would need its own clinical assessment.
Risks and costs
Catheter procedures can cause bleeding, vein injury and blood clots, and stents add risks such as migration. Although the small randomized trials did not report serious procedure-attributable events, the FDA's historical warning described serious injuries and deaths associated with real-world CCSVI interventions. Private procedures, travel and management of complications create costs without demonstrated MS benefit. Replacing or delaying a proven DMT for "liberation" treatment adds the risk of untreated MS activity.
Questions to bring to your neurologist
- Can we review the sham-controlled trial findings rather than testimonials about this procedure?
- Is there any independently diagnosed vascular problem requiring treatment for reasons unrelated to MS?
- Which evidence-based options best address my current MS activity and symptoms?
Sources
- Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial (RCT, 2017)
- The technique popularly known as "liberation procedure" for treatment of venous stenoses (CCSVI) in the brain of people with MS (Review, 2019)
- FDA warns MS patients about risky stent treatment (Report, 2012)
This is information, not medical advice. Talk to your neurologist before changing anything.
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error